Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic and Multiple Myeloma Bone Tumors for the Palliation of Pain in Patients Who Are Not Candidates for Radiation Therapy

NCT00656305 is registered in ClinicalTrials.gov with InSightec as lead sponsor.

NCT NCT00656305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00656305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic and Multiple Myeloma Bone Tumors for the Palliation of Pain in Patients Who Are Not Candidates for Radiation Therapy
Lead sponsor
InSightec
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2008
Completion date
September 30, 2012
Enrollment
147 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, multiple myeloma